We are live on !
Find out more
Wealth Effects Portfolio holdings
AUM
$370M
Turnover
11.85%
1-Year Est. Return
63.53%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+63.53%
3 Year Est. Return
+235.32%
5 Year Est. Return
+296.21%
10 Year Est. Return
–
AUM
$282M
AUM Growth
-$3.93M
(-1.4%)
Cap. Flow
-$6.27M
Cap. Flow % of AUM
Cap. Flow %
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
46%
Holding
230
New
13
Increased
66
Reduced
108
Closed
18
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.34M |
| 2 |
Devon Energy
DVN
|
+$744K |
| 3 |
Elastic
ESTC
|
+$539K |
| 4 |
Micron Technology
MU
|
+$513K |
| 5 |
Palantir
PLTR
|
+$449K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novo Nordisk
NVO
|
+$844K |
| 2 |
Eagle Materials
EXP
|
+$808K |
| 3 |
NVIDIA
NVDA
|
+$712K |
| 4 |
Impinj
PI
|
+$675K |
| 5 |
Apple
AAPL
|
+$650K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Miscellaneous | 20.78% |
| 3 | Healthcare | 15.37% |
| 4 | Communication Services | 8.73% |
| 5 | Financials | 7.38% |
Similar funds
WMA
BC
Wealth Effects's Q4 2024 Portfolio in Review
As of Q4 2024, Wealth Effects held 230 positions worth $282M, down 1.4% from $285M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Wealth Effects's Q4 2024 filing shows 13 new, 66 increased, 108 reduced and 18 closed positions. Its largest new stake was Palantir: 7,714 shares worth $583K. The largest sale was Novo Nordisk, an estimated $844K.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Miscellaneous and Healthcare.
- Wealth Effects's largest Q4 2024 buy was Palantir: 7,714 shares worth $583K.
- Wealth Effects added most to Avadel Pharmaceuticals in Q4 2024, an estimated $1.34M increase.
- Wealth Effects's biggest Q4 2024 reduction was Eagle Materials, cutting an estimated $808K.
- Wealth Effects fully exited Novo Nordisk in Q4 2024, selling an estimated $844K.
- Wealth Effects's ten largest holdings make up 46% of its $282M portfolio in Q4 2024.
- Wealth Effects opened 13 new positions and closed 18 in Q4 2024.
- Wealth Effects's portfolio value fell 1.4% quarter-over-quarter to $282M.
Based on Wealth Effects's 13F filing for Q4 2024, filed 22 Jan 2025.